Thermo Fisher Scientific Inc.
TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$682.65−14.35 (-2.06%)
Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%
Thermo Fisher Scientific Injury MDRs — Thermo Fisher: 11 in Q3 2026, unchanged from a year earlier.
Latest, Q3 2026
11
Period ended Sep 30, 2026
Change on a year earlier
0.0%
11 in Q3 2025
History
43 quarters
Since Q1 2016
Sources
1
openFDA MAUDE Injury Reports — Thermo Fisher & Subsidiaries
Where the Q3 2026 figure comes from
Source: openFDA MAUDE Injury Reports — Thermo Fisher & Subsidiaries ↗
Reported in U.S. FDA openFDA MAUDE Adverse Event API.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Thermo Fisher Scientific Injury MDRs — Thermo Fisher, quarterly Q1 2016–Q3 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/fda-maude-injury
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.